{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T04:34:46Z","timestamp":1715661286911},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T00:00:00Z","timestamp":1333411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00296-012-2414-4","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T06:44:17Z","timestamp":1333349057000},"page":"601-605","source":"Crossref","is-referenced-by-count":4,"title":["Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Jamileh","family":"Moghimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheb","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnaz","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Sheikhvatan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,3]]},"reference":[{"key":"2414_CR1","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2009.122739","volume":"69","author":"BJ Miriovsky","year":"2010","unstructured":"Miriovsky BJ, Michaud K, Thiele GM et al (2010) Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Ann Rheum Dis 69:1292\u20131297","journal-title":"Ann Rheum Dis"},{"key":"2414_CR2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360701295623","volume":"44","author":"A Raptopoulou","year":"2007","unstructured":"Raptopoulou A, Sidiropoulos P, Katsouraki M et al (2007) Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit Rev Clin Lab Sci 44:339\u2013363","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2414_CR3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845\u2013851","journal-title":"Ann Rheum Dis"},{"key":"2414_CR4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360701295623","volume":"44","author":"A Raptopoulou","year":"2007","unstructured":"Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT (2007) Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit Rev Clin Lab Sci 44:339\u2013363","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2414_CR5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3\u00a0years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085\u20131089","journal-title":"Ann Rheum Dis"},{"key":"2414_CR6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","volume":"46","author":"KP Machold","year":"2007","unstructured":"Machold KP, Stamm TA, Nell VP et al (2007) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first year of disease. Rheumatology (Oxford) 46:342\u2013349","journal-title":"Rheumatology (Oxford)"},{"key":"2414_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U et al (2006) Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 65:453\u2013458","journal-title":"Ann Rheum Dis"},{"key":"2414_CR8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E Lindqvist","year":"2005","unstructured":"Lindqvist E, Eberhardt K, Bendtzen K et al (2005) Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 64:196\u2013201","journal-title":"Ann Rheum Dis"},{"key":"2414_CR9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1186\/ar1767","volume":"7","author":"AH Helm-van Mil van der","year":"2005","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC et al (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:949\u2013958","journal-title":"Arthritis Res Ther"},{"key":"2414_CR10","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J R\u00f6nnelid","year":"2005","unstructured":"R\u00f6nnelid J, Wick MC, Lampa J et al (2005) Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5\u00a0years follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744\u20131749","journal-title":"Ann Rheum Dis"},{"key":"2414_CR11","doi-asserted-by":"crossref","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:144\u2013163","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3"},{"key":"2414_CR12","doi-asserted-by":"crossref","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA et al (2000) The prognostic value of anti-cyclic itrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831\u20131835","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6"},{"key":"2414_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"2414_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/ar2945","volume":"12","author":"M Singwe-Ngandeu","year":"2010","unstructured":"Singwe-Ngandeu M, Finckh A, Bas S, Tiercy JM, Gabay C (2010) Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients. Arthritis Res Ther 12:36","journal-title":"Arthritis Res Ther"},{"key":"2414_CR15","first-page":"36","volume":"2","author":"D Predeteanu","year":"2009","unstructured":"Predeteanu D, Varzaru L, Balanescu A et al (2009) Anti-cyclic citrullinated peptide antibodies-activity markers in rheumatoid arthritis. J Med Life 2:36\u201341","journal-title":"J Med Life"},{"key":"2414_CR16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1515\/CCLM.2010.046","volume":"48","author":"SM Hwang","year":"2010","unstructured":"Hwang SM, Kim JO, Yoo YM et al (2010) Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis. Clin Chem Lab Med 48:225\u2013230","journal-title":"Clin Chem Lab Med"},{"key":"2414_CR17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4103\/0256-4947.57170","volume":"29","author":"B Heidari","year":"2009","unstructured":"Heidari B, Firouzjahi A, Heidari P, Hajian K (2009) The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis. Ann Saudi Med 29:467\u2013470","journal-title":"Ann Saudi Med"},{"key":"2414_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00296-009-0980-x","volume":"30","author":"E Aflaky","year":"2010","unstructured":"Aflaky E, Shenavandeh S, Ashraf MJ (2010) A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients Iran. Rheumatol Int 30:461\u2013466","journal-title":"Rheumatol Int"},{"key":"2414_CR19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-152-7-201004060-00010","volume":"152","author":"PF Whiting","year":"2010","unstructured":"Whiting PF, Smidt N, Sterne JA et al (2010) Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Int Med 152:456\u2013464","journal-title":"Ann Int Med"},{"key":"2414_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1756-185X.2009.01412.x","volume":"12","author":"S Sockalingam","year":"2009","unstructured":"Sockalingam S, Khuan CS, Sthaneshwar P (2009) Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity. Int J Rheum Dis 12:211\u2013215","journal-title":"Int J Rheum Dis"},{"key":"2414_CR21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Int Med 146:797\u2013808","journal-title":"Ann Int Med"},{"key":"2414_CR22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2169\/internalmedicine.44.1122","volume":"44","author":"T Mimori","year":"2005","unstructured":"Mimori T (2005) Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Int Med 44:1112\u20131126","journal-title":"Int Med"},{"key":"2414_CR23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1515\/CCLM.2010.152","volume":"48","author":"D Pietrapertosa","year":"2010","unstructured":"Pietrapertosa D, Tolusso B, Gremese E et al (2010) Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios. Clin Chem Lab Med 48:829\u2013834","journal-title":"Clin Chem Lab Med"},{"key":"2414_CR24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10067-010-1374-x","volume":"29","author":"B Hodkinson","year":"2010","unstructured":"Hodkinson B, Meyer PW, Musenge E et al (2010) The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol 29:615\u2013618","journal-title":"Clin Rheumatol"},{"key":"2414_CR25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10067-009-1337-2","volume":"29","author":"H Li","year":"2010","unstructured":"Li H, Song W, Li Y et al (2010) Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29:413\u2013417","journal-title":"Clin Rheumatol"},{"key":"2414_CR26","first-page":"68","volume":"22","author":"HK Lin","year":"2008","unstructured":"Lin HK, Lan JL, Chen DY et al (2008) The diagnostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis. Formos J Rheum 22:68\u201373","journal-title":"Formos J Rheum"},{"key":"2414_CR27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3346\/jkms.2005.20.3.473","volume":"20","author":"SW Choi","year":"2005","unstructured":"Choi SW, Lim MK, Shin DH, Park JJ, Shim SC (2005) Diagnostic performances of anti-cyclic citrullinated peptides antibody and antiWlaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci 20:473\u2013478","journal-title":"J Korean Med Sci"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2414-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2414-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2414-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T12:57:45Z","timestamp":1561553865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2414-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2414"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2414-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,3]]}}}